Ajaz Hussain

fda qbd pat quality assurance quality us fda quality by design pharmaceuticals pharmaceutical cgmp professional development gmp biosimilars design development culture india generics system maturity nipte therapeutic equivalence cmc risk data systems thinking ich q10 fda cder integrity validation continulal professional development order of conciousness generic drugs 21st century cures act quality control data integrity continued process verificaiton qms voice of patients warning letters usa behavior ich q8 good professional placebo pharmaceutical equivalence process bioequivalence real world adult human develoment continuous improvement continuous manufactruing conciousness experience complexity complex office of pharmaceutical quality inspection evidence ema manufacturing chaos internal validation control systems regulatory science ich q9 import alert compliance science interchangeability substitution uncertainty patients usp practices confidence assurance industry 4.0 external validaiton technology self-authored form 483 biotechnology nocebo affordability leadership fda qbd gmp cmc review inspection metrics design r pharmaceutical technology management irrational vaccine practice equivalence human statistical dissolution smart orders of conciousness user experience expectation engineering education nist pharmaceutical industry design thinking education and training knowledge managment excipients china breaches warning letter managment cheating quality management system biases pharmacy industry ich methylphenidate adhd behavioral economics pharmaceutical engineering review regulation hussain professionaljourney by desing pharma 4.0 gcp glp quantity qualia fractals satisfaction new prior knowledge community of knowledge knowledge management inequality customer experience adhearance experience economy pay for performacne expereince economy one quality voice certification expereince training invalidated oos rate oos emotions regualtion culture of pharmaceutical quality insight supply chain cost of drugs manufactruing usa uncertinty cmc review risk management knowledge big data sameness statistics therapeutic recalls value patient safety cognitive drug regulation formulation sciences q10 subject by formulation generic pharmacist concerta challenges regulatory communication question based development voice pat cppr nipte desing drug shortages measurement calibrator capability errors regulations medicine personalized similarity blind-spots eu comparability inspections safety efficacy nanotechnology controls continuous understanding bcs ajaz ajaz hussain regulatory uncertainty thinking shepherding charecterization advanced analytics streamline fda thai antibodies monoclonal change management pharmacy to the world health care concionsness sfda regulator instiution intution resilience theraputic generic drug serialization dscsa mangement revolution industry 4 pharma 4 process validaiton validaiton conciousess desing matruity adulthood audit interest cognative mandates law aloca post-truth immaturity evil #assurance #quality #self-authership #orders #laws #lifespiral #lifecycle #control #regualtion #capability #suitability #development #maturity #gcp #glp #gmp #good #practices #validaiton good practices sustainability smartfactory smartphones emergent borg professional journey supac ich 14 21st century best practices faculty doe orders of consciousness 2020 cphi aaps new drugs qulaity malcom baldridge award r residual uncertainty totality of evidence weight of evidence repurposing theraputics covid19 pharmaceutical engineering science consciousness contol suitability capa special cause common cause comission omission quality system constructive development theory inactive ingredient guide ich q11 ich q12 leadership development clinical trials mrtp smoking vaping harm reduction personal pqri wisdom information technology certificaiton excipientes ifpac theraputic equivalence brand drugs levothyroxine emotional processing rumination lifecycle outcome income efficiency ecology one voice comlexity availability process validation import alerts product withdrawals epistemology theory of knowledge deming adult development inteligence emotional chemical biotech branding industrial engineering msc adpharming alcoa badi metrics real-time controls socialized mind selfconfidence happiness interchnageability email marketing process analytical technology globalization makeing in america software part 11 advice ajaz s. hussain quality of drugs trump transformation president-elect niimbl crtitical path nasal sprary bioequivalence generic snakes and ladders rumi six blind men and the elephant angle of repose elephant in the dark tipping point cmo qbd. 21st century patheon bla nda defaults anda mhra who persistance passion six sigma integrated qbr gdufa trust epistemic price pressure health canada canada emerging economies violations 483 pharma eurpoe equivance quaity generic< medicine organizational blind reliability pharmacopoeias careing drug utilisation pharmacokinetics and pharmacodynamics drug discovery 2014 university next generation educating panjab oration biowaiver food & drug administration pat team q9 q8 q12 q11 interaction replicate tablets biosimilar disorder lack of effect ab rating patient attention deficit interchangeeability complaints haikudeck economics argumentation integrative thinking opportunities breakthrough therapy designation fdasia amos tversky daniel kahneman malaria specifications opq pharmaceutics pharmacokinetics system. testing tablet habits keystone fraud subconscious fear econometric consciously counterfeits behaviour heparin complinace real time release cancer biomarkers mechanistic exposure response trial and error predictive target logic communication row profile failure thniking integrative gauge r&r epa factors preventive attitude cluster perception poor norms team collaboration classification biopharmaceutics econometrics chemometrics pharmacometrics drugs devices intention risk managment pragmatic implementation innovation quality-by-design